These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 21441467

  • 21. Ocular distribution of difluprednate ophthalmic emulsion 0.05% in rabbits.
    Tajika T, Isowaki A, Sakaki H.
    J Ocul Pharmacol Ther; 2011 Feb; 27(1):43-9. PubMed ID: 21118027
    [Abstract] [Full Text] [Related]

  • 22. Pharmacokinetics and intraocular pressure-lowering activity of TAK-639, a novel C-type natriuretic peptide analog, in rabbit, dog, and monkey.
    Savinainen A, Prusakiewicz JJ, Oswald J, Spencer E, Lou Z, Cohen ML, Rashidzadeh H, Josiah S.
    Exp Eye Res; 2019 Dec; 189():107836. PubMed ID: 31626797
    [Abstract] [Full Text] [Related]

  • 23. Comparative ocular pharmacokinetics of brimonidine after a single dose application to the eyes of albino and pigmented rabbits.
    Acheampong AA, Shackleton M, Tang-Liu DD.
    Drug Metab Dispos; 1995 Jul; 23(7):708-12. PubMed ID: 7587958
    [Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics of Sirolimus Eye Drops Following Topical Ocular Administration in Rabbits.
    Lin J, Lu Z, Wang Y, Zhang J, Guo J, Huang Y, Lin B, Yang W.
    J Ocul Pharmacol Ther; 2023 Dec; 39(10):735-743. PubMed ID: 37579189
    [Abstract] [Full Text] [Related]

  • 25. Concentrations of betaxolol in ocular tissues of patients with glaucoma and normal monkeys after 1 month of topical ocular administration.
    Holló G, Whitson JT, Faulkner R, McCue B, Curtis M, Wieland H, Chastain J, Sanders M, DeSantis L, Przydryga J, Dahlin DC.
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):235-40. PubMed ID: 16384968
    [Abstract] [Full Text] [Related]

  • 26. Pharmacokinetics of falintolol II. Absorption, distribution and elimination from tissues and organs following ocular administration and intravenous injection of falintolol in albino rabbits.
    Andermann G, Guggenbuhl P, de Burlet G, Himber J.
    Methods Find Exp Clin Pharmacol; 1989 Dec; 11(12):747-54. PubMed ID: 2576299
    [Abstract] [Full Text] [Related]

  • 27. Ocular pharmacokinetics of intravitreally administered brimonidine and dexamethasone in animal models with and without blood-retinal barrier breakdown.
    Shen J, Durairaj C, Lin T, Liu Y, Burke J.
    Invest Ophthalmol Vis Sci; 2014 Feb 20; 55(2):1056-66. PubMed ID: 24448267
    [Abstract] [Full Text] [Related]

  • 28. Distribution of topical ocular nepafenac and its active metabolite amfenac to the posterior segment of the eye.
    Chastain JE, Sanders ME, Curtis MA, Chemuturi NV, Gadd ME, Kapin MA, Markwardt KL, Dahlin DC.
    Exp Eye Res; 2016 Apr 20; 145():58-67. PubMed ID: 26474497
    [Abstract] [Full Text] [Related]

  • 29. Ocular Penetration and Pharmacokinetics of Ripasudil Following Topical Administration to Rabbits.
    Isobe T, Kasai T, Kawai H.
    J Ocul Pharmacol Ther; 2016 Sep 20; 32(7):405-14. PubMed ID: 27463221
    [Abstract] [Full Text] [Related]

  • 30. Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye.
    Furrer E, Berdugo M, Stella C, Behar-Cohen F, Gurny R, Feige U, Lichtlen P, Urech DM.
    Invest Ophthalmol Vis Sci; 2009 Feb 20; 50(2):771-8. PubMed ID: 18757508
    [Abstract] [Full Text] [Related]

  • 31. Comparative assessment of distribution of blackcurrant anthocyanins in rabbit and rat ocular tissues.
    Matsumoto H, Nakamura Y, Iida H, Ito K, Ohguro H.
    Exp Eye Res; 2006 Aug 20; 83(2):348-56. PubMed ID: 16635490
    [Abstract] [Full Text] [Related]

  • 32. Anti-inflammatory effects of mapracorat, a novel selective glucocorticoid receptor agonist, is partially mediated by MAP kinase phosphatase-1 (MKP-1).
    Vollmer TR, Stockhausen A, Zhang JZ.
    J Biol Chem; 2012 Oct 12; 287(42):35212-35221. PubMed ID: 22898817
    [Abstract] [Full Text] [Related]

  • 33. Conjunctival tissue pharmacokinetic properties of topical azithromycin 1% and moxifloxacin 0.5% ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteers.
    Torkildsen G, O'Brien TP.
    Clin Ther; 2008 Nov 12; 30(11):2005-14. PubMed ID: 19108788
    [Abstract] [Full Text] [Related]

  • 34. Ocular pharmacokinetics and hypotensive activity of PF-04475270, an EP4 prostaglandin agonist in preclinical models.
    Prasanna G, Fortner J, Xiang C, Zhang E, Carreiro S, Anderson S, Sartnurak S, Wu G, Gukasyan H, Niesman M, Nair S, Rui E, Lafontaine J, Almaden CD, Wells P, Krauss A.
    Exp Eye Res; 2009 Nov 12; 89(5):608-17. PubMed ID: 19445930
    [Abstract] [Full Text] [Related]

  • 35. Distribution of brimonidine into anterior and posterior tissues of monkey, rabbit, and rat eyes.
    Acheampong AA, Shackleton M, John B, Burke J, Wheeler L, Tang-Liu D.
    Drug Metab Dispos; 2002 Apr 12; 30(4):421-9. PubMed ID: 11901096
    [Abstract] [Full Text] [Related]

  • 36. Ocular pharmacokinetics of dorzolamide and brinzolamide after single and multiple topical dosing: implications for effects on ocular blood flow.
    Kadam RS, Jadhav G, Ogidigben M, Kompella UB.
    Drug Metab Dispos; 2011 Sep 12; 39(9):1529-37. PubMed ID: 21673129
    [Abstract] [Full Text] [Related]

  • 37. Ocular pharmacokinetics of thiamphenicol in rabbits.
    Aldana I, Fos D, Gonzalez Peñas E, Gazzaniga A, Gianesello V, Ceppi Monti N, Figini PG, Zato MA, Bruseghini L, Esteras A.
    Arzneimittelforschung; 1992 Oct 12; 42(10):1236-9. PubMed ID: 1472144
    [Abstract] [Full Text] [Related]

  • 38. Retinoid metabolism and transplacental pharmacokinetics in the cynomolgus monkey following a nonteratogenic dosing regimen with all-trans-retinoic acid.
    Tzimas G, Nau H, Hendrickx AG, Peterson PE, Hummler H.
    Teratology; 1996 Nov 12; 54(5):255-65. PubMed ID: 9035347
    [Abstract] [Full Text] [Related]

  • 39. Tolerability and pharmacokinetics of intravitreal sirolimus.
    Mudumba S, Bezwada P, Takanaga H, Hosoi K, Tsuboi T, Ueda K, Kawazu K, Ali Y, Naor J.
    J Ocul Pharmacol Ther; 2012 Oct 12; 28(5):507-14. PubMed ID: 22662868
    [Abstract] [Full Text] [Related]

  • 40. Preparation of 0.05% FK506 suspension eyedrops and its pharmacokinetics after topical ocular administration.
    Yuan J, Zhai JJ, Chen JQ, Ye CT, Zhou SY.
    J Ocul Pharmacol Ther; 2009 Aug 12; 25(4):345-50. PubMed ID: 19492954
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.